These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19551353)

  • 41. Association between meibomian gland changes and aging, sex, or tear function.
    Den S; Shimizu K; Ikeda T; Tsubota K; Shimmura S; Shimazaki J
    Cornea; 2006 Jul; 25(6):651-5. PubMed ID: 17077655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pattern of vital staining and its correlation with aqueous tear deficiency and meibomian gland dropout.
    Uchiyama E; Aronowicz JD; Butovich IA; McCulley JP
    Eye Contact Lens; 2007 Jul; 33(4):177-9. PubMed ID: 17630624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Self-reported compliance with topical cyclosporine emulsion 0.05% and onset of the effects of increased tear production as assessed through patient surveys.
    Trattler W; Katsev D; Kerney D
    Clin Ther; 2006 Nov; 28(11):1848-56. PubMed ID: 17213005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up.
    Sahin A; Bozkurt B; Irkec M
    Cornea; 2008 Feb; 27(2):193-5. PubMed ID: 18216575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology.
    Martone G; Frezzotti P; Tosi GM; Traversi C; Mittica V; Malandrini A; Pichierri P; Balestrazzi A; Motolese PA; Motolese I; Motolese E
    Am J Ophthalmol; 2009 Apr; 147(4):725-735.e1. PubMed ID: 19181302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficacy of topical metronidazole in the treatment of ocular rosacea.
    Barnhorst DA; Foster JA; Chern KC; Meisler DM
    Ophthalmology; 1996 Nov; 103(11):1880-3. PubMed ID: 8942885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical ophthalmic cyclosporine: pharmacology and clinical uses.
    Donnenfeld E; Pflugfelder SC
    Surv Ophthalmol; 2009; 54(3):321-38. PubMed ID: 19422961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcome of treatment of mooren ulcer with topical cyclosporine a 2%.
    Tandon R; Chawla B; Verma K; Sharma N; Titiyal JS
    Cornea; 2008 Sep; 27(8):859-61. PubMed ID: 18724142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.
    Thiboutot DM; Fleischer AB; Del Rosso JQ; Rich P
    J Drugs Dermatol; 2009 Jul; 8(7):639-48. PubMed ID: 19588640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful tear lipid layer treatment for refractory dry eye in office workers by low-dose lipid application on the full-length eyelid margin.
    Goto E; Dogru M; Fukagawa K; Uchino M; Matsumoto Y; Saiki M; Tsubota K
    Am J Ophthalmol; 2006 Aug; 142(2):264-70. PubMed ID: 16876507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phlyctenular keratoconjunctivitis in a patient with Staphylococcal blepharitis and ocular rosacea.
    Neiberg MN; Sowka J
    Optometry; 2008 Mar; 79(3):133-7. PubMed ID: 18302955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topical cyclosporine A in the prevention of pterygium recurrence.
    Yalcin Tok O; Burcu Nurozler A; Ergun G; Akbas Kocaoglu F; Duman S
    Ophthalmologica; 2008; 222(6):391-6. PubMed ID: 18765950
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ophthalmic cyclosporine use in ocular GVHD.
    Lelli GJ; Musch DC; Gupta A; Farjo QA; Nairus TM; Mian SI
    Cornea; 2006 Jul; 25(6):635-8. PubMed ID: 17077652
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short-term effects of topical cyclosporine A 0.05% (Restasis) in long-standing prosthetic eye wearers: a pilot study.
    Han JW; Yoon JS; Jang SY
    Eye (Lond); 2014 Oct; 28(10):1212-7. PubMed ID: 25081289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and laboratory study of ocular rosacea in northern Greece.
    Lazaridou E; Fotiadou C; Ziakas NG; Giannopoulou C; Apalla Z; Ioannides D
    J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1428-31. PubMed ID: 21366706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood.
    Spadavecchia L; Fanelli P; Tesse R; Brunetti L; Cardinale F; Bellizzi M; Rizzo G; Procoli U; Bellizzi G; Armenio L
    Pediatr Allergy Immunol; 2006 Nov; 17(7):527-32. PubMed ID: 17014629
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tear film lipid layer thickness and ocular comfort after meibomian therapy via latent heat with a novel device in normal subjects.
    Mitra M; Menon GJ; Casini A; Hamada S; Adams D; Ricketts C; Fuller ET; Fuller JR
    Eye (Lond); 2005 Jun; 19(6):657-60. PubMed ID: 15332095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitis.
    Rubin M; Rao SN
    J Ocul Pharmacol Ther; 2006 Feb; 22(1):47-53. PubMed ID: 16503775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pediatric ocular acne rosacea: long-term treatment with systemic antibiotics.
    Cetinkaya A; Akova YA
    Am J Ophthalmol; 2006 Nov; 142(5):816-21. PubMed ID: 17056363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in meibomian fatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment.
    Souchier M; Joffre C; Grégoire S; Bretillon L; Muselier A; Acar N; Beynat J; Bron A; D'Athis P; Creuzot-Garcher C
    Br J Ophthalmol; 2008 Jun; 92(6):819-22. PubMed ID: 18511542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.